Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial - Grothey, A; Van Cutsem, E; Sobrero, A; Siena, S; Falconi, A; Ychou, M (Lancet, 2013)